Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty [9]

Paul A. Lotke, John J. Callaghan, Lawrence D. Dorr, Gerard H. Engh, Arlen D. Hanssen, William L. Healy, Paul F. Lachiewicz, Jess H. Lonner, Charles Nelson, Chitranjan S. Ranawat, Merrill A. Ritter, Eduarde A. Salvati, Thomas P. Sculco, Thomas S. Thornhill

Research output: Contribution to journalLetter

1 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalJournal of Bone and Joint Surgery - Series A
Volume88
Issue number5
DOIs
StatePublished - May 2006

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Lotke, P. A., Callaghan, J. J., Dorr, L. D., Engh, G. H., Hanssen, A. D., Healy, W. L., Lachiewicz, P. F., Lonner, J. H., Nelson, C., Ranawat, C. S., Ritter, M. A., Salvati, E. A., Sculco, T. P., & Thornhill, T. S. (2006). Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty [9]. Journal of Bone and Joint Surgery - Series A, 88(5). https://doi.org/10.2106/00004623-200605000-00039